Increase funding for public health campaigns to improve vaccine uptake and counter misinformation.
Pandemics
Pandemics Risk
Assessment for this date
Today's pandemic risk is moderate due to rising COVID-19 cases, new outbreaks of polio and measles, and ongoing challenges with vaccine uptake and misinformation.
August 2, 2025
Trend
Viewing the record for August 2, 2025 within the full trend.
Risk Drivers
What is pushing the current reading.
The current global health landscape is marked by a slight increase in COVID-19 cases in the US, alongside new polio cases in multiple countries and measles outbreaks in Michigan. Despite the availability of effective vaccines, uptake remains low in certain high-risk groups, such as cancer patients, and misinformation continues to undermine public trust in vaccination efforts. Surveillance tools are improving, as seen with wastewater monitoring for COVID-19, but gaps remain, particularly in the detection and response to emerging variants and other infectious diseases like H5N1 and MERS. These factors collectively contribute to a sustained moderate risk level, with potential for escalation if public health measures and vaccine uptake do not improve.
Risk Reduction Actions
Priority actions generated from the current analysis.
Enhance outreach and education efforts to ensure high-risk populations receive vaccinations.
Continue development and deployment of advanced surveillance tools to detect emerging infectious diseases.
Coordinate global efforts to address outbreaks of polio, measles, and other infectious diseases.
Promote accurate information about vaccine safety and efficacy to combat misinformation.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- Quick Takes: US COVID uptick, new polio cases in 4 countries, measles outbreak in Michigan
- US COVID levels continue slight upward trend
- US COVID levels rise a bit in West, South
- COVID-19 vaccines offer strong protection for cancer patients, but uptake remains low
- FDA approves Moderna COVID vaccine for kids under 12 at higher risk